Sensible Biotechnologies, Inc.
Sensible Biotechnologies is pioneering a new era of design-based biology with its cell-based mRNA design and manufacturing platform, enabling the production of pure, low immunogenicity mRNA. The company aims to overcome the limitations of synthetic mRNA and unlock the potential of RNA therapeutics.
Industries
biotechnology
medical
Nr. of Employees
small (1-50)
Sensible Biotechnologies, Inc.
Bratislava, Bratislava, Slovakia (Slovak Republic), Europe
Products
Cell-based mRNA design and manufacturing platform
A platform that combines cell-based production methods with computational design to produce mRNA intended for therapeutic use with reduced immunogenicity.
Cell-based mRNA design and manufacturing platform
A platform that combines cell-based production methods with computational design to produce mRNA intended for therapeutic use with reduced immunogenicity.
Services
Collaborative computational engine development
Joint development projects to build a computational engine for design of cell-based mRNA therapeutics, integrating high-performance compute and machine learning methods.
Collaborative computational engine development
Joint development projects to build a computational engine for design of cell-based mRNA therapeutics, integrating high-performance compute and machine learning methods.
Expertise Areas
- Cell-based mRNA therapeutics
- mRNA manufacturing
- Computational therapeutic design
- Synthetic biology / design-based biology
Key Technologies
- Cell-based mRNA production
- AI/ML-driven molecular design
- Accelerated computing for biological modelling
- Computational design engines for therapeutics